Form 4: VSEE Health Director Fairfax Acquires 68,397 Shares

VSEE Health, Inc. director Cydonii V. Fairfax reported the acquisition of 68,397 shares of common stock through multiple grants for director services.

Summary

• Director Cydonii V. Fairfax acquired a total of 68,397 shares of VSEE Health, Inc. common stock.
• These shares were issued under the issuer's 2024 Incentive Plan as compensation for director services.
• The acquisitions relate to services performed during the quarters ended September 30, 2024, December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025.
• The shares were valued based on the closing price of the common stock on specific dates corresponding to the end of each service quarter, ranging from $0.69 to $1.49 per share.
• Following these transactions, Cydonii V. Fairfax beneficially owns 68,397 shares of VSEE Health, Inc. common stock.

Sentiment

Score: 7

Explanation: The filing indicates a director's increased stake in the company through compensation, which is generally a positive signal of alignment and confidence. However, it's a routine disclosure and does not provide new operational or financial performance information.

Positives

• Director Cydonii V. Fairfax increased their beneficial ownership by a total of 68,397 shares, demonstrating continued alignment with shareholder interests.
• The grants are part of a non-employee director compensation policy, indicating a structured approach to rewarding board members with equity.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance, as it primarily reports historical changes in beneficial ownership.

Industry Context

This filing reflects routine compensation practices for non-employee directors, where equity grants are used to align director interests with long-term shareholder value. Such practices are common across various industries, including healthcare technology, where VSEE Health operates.

Comparison to Industry Standards

• The use of equity grants as compensation for non-employee directors is a standard practice across publicly traded companies, aligning director incentives with shareholder value.
• The specific valuation method, based on closing prices at quarter-end, is a common and transparent approach.
• Without specific details on VSEE Health's peer group compensation structures, a direct comparison of the amount of compensation is not possible from this filing alone. However, the method of compensation aligns with general industry standards for corporate governance and executive/director remuneration.

Related Party Transactions

• Cydonii V. Fairfax, a director, received 68,397 shares of common stock as compensation for services under the issuer's 2024 Incentive Plan, consistent with the non-employee director compensation policy.

Stakeholder Impact

• Shareholders: Increased beneficial ownership by a director can be seen as a positive signal of confidence in the company's future.

Key Dates

Keywords

VSEE Health, VSEE, Form 4, Insider Trading, Director Compensation, Stock Grant, Equity Acquisition, Beneficial Ownership, Incentive Plan